Glucagon-like peptide-1 receptor agonists-how safe are they
Then, based on your feedbackhow you're feeling, your appetite levels, any side effectsyour provider will guide you on when and how to slowly increase the dose
Seek help and advice
CrossRef Prognostic value of non-invasive fibrosis assessment scores in predicting mortality among individuals with metabolic dysfunction-associated steatotic liver disease Lingjie Wu, Shunling Cai, Zhongbin Lin, Ruilie Chen, Yuanfeng Zhang, Xiaobing Gong BMC Public Health .2026;[Epub] CrossRef Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments Jaejun Lee, Hyun Yang, Si Hyun Bae, Hee Sun Cho, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Keungmo Yang, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Seok Hwan Kim, Myung Jun Song, Soon Kyu Lee, Jung H Liver Cancer .2026
These estimates bridge the obese and lean trial populations
seek urgent medical advice for right upper quadrant pain or jaundice Diabetic retinopathy complications : Patients with pre-existing retinopathy should have regular ophthalmological monitoring, as rapid glycaemic improvement may temporarily worsen retinal disease Renal impairment : Dehydration from gastrointestinal side effects can affect kidney function, particularly in vulnerable patients Injection site reactions (redness, itching, bruising) are common but usually mild
